lncRNA ROR Promotes Gastric Cancer Drug Resistance
Objective: Gastric cancer is one of the most common malignant tumors worldwide, and for resectable tumors, the most effective treatment is surgery with chemotherapy in neoadjuvant or adjuvant setting. However, the majority of patients fail to achieve the ideal initial response and/or develop resista...
Main Authors: | Shuai Wang PhD, Wujun Chen MD, Hualong Yu PhD, Zhengming Song MD, Qian Li PhD, Xin Shen PhD, Yudong Wu PhD, Lei Zhu PhD, Qingxia Ma PhD, Dongming Xing PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-01-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/1073274820904694 |
Similar Items
-
A Novel LncRNA SNHG3 Promotes Osteoblast Differentiation Through BMP2 Upregulation in Aortic Valve Calcification
by: Long Chen, MD, et al.
Published: (2022-09-01) -
LncRNA OIP5-AS1 Promotes the Autophagy-Related Imatinib Resistance in Chronic Myeloid Leukemia Cells by Regulating miR-30e-5p/ATG12 Axis
by: Hongdan Dai MS, et al.
Published: (2021-10-01) -
COLEC12 Promotes Tumor Progression and Is Correlated With Poor Prognosis in Gastric Cancer
by: Xiangfei Sun PhD, et al.
Published: (2023-12-01) -
Oncological Impact of Gross Proximal Margin Length in Distal Gastrectomy for Gastric Cancer: Is the Japanese Recommendation Valid?
by: Masaru Hayami, MD, PhD, et al.
Published: (2021-03-01) -
Persistent Postgastrectomy Hypoglycemia Unawareness in Patients With Gastric Cancer Unveiled by a Prospective Study
by: Takeshi Kubota, MD, PhD, et al.
Published: (2022-03-01)